about
Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial.Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.Obstructive sleep apnea and serious adverse outcomes in patients with cardiovascular or cerebrovascular disease: a PRISMA-compliant systematic review and meta-analysisImpact of cardiovascular disease deaths on life expectancy in Chinese population.Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi-Provincial Cohort Study.Further evidence for genetic association of CACNA1C and schizophrenia: new risk loci in a Han Chinese population and a meta-analysis.Medical Plants and Immunological Regulation.Five-year change in systolic blood pressure is independently associated with carotid atherosclerosis progression: a population-based cohort study
P50
Q34387399-3612EC87-D017-46ED-9332-34181D40F0ACQ35882508-F443F511-47AB-454A-8B77-DACC8D5F10A3Q36151805-DA42CEE3-3A68-403E-B400-8AD186D05ED2Q39214396-B2947EBB-8E2C-487D-BD3B-8BB7BC7E5E34Q39295261-2720AE7C-930A-4CC6-A3F4-98F86F016A20Q43749466-A62C2321-F6D9-42AB-82E8-DB15D41D3059Q64899778-E5DBABC0-3B11-433B-A789-7B0CF684B0C4Q87827337-5ED9C32D-EFD5-4D51-983B-4266AA618EC3
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Wuxiang Xie
@en
Wuxiang Xie
@nl
type
label
Wuxiang Xie
@en
Wuxiang Xie
@nl
prefLabel
Wuxiang Xie
@en
Wuxiang Xie
@nl
P31
P496
0000-0001-7527-1022